Keyphrases
Autism Spectrum Disorder
100%
Childhood Autism
100%
Endocannabinoid Levels
100%
Endocannabinoid System
80%
N-oleoylethanolamine
80%
N-palmitoylethanolamine
80%
Serum Levels
60%
Arachidonic Acid
40%
2-Arachidonoylglycerol (2-AG)
40%
Autism Mouse Model
40%
Adaptive Functioning
40%
Synaptic Plasticity
20%
Disease Pattern
20%
Clinically Significant
20%
Young Age
20%
Child Age
20%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
20%
Endocannabinoids
20%
Neurotypical
20%
Dysregulation
20%
Autism Diagnostic Observation Schedule
20%
Autism Spectrum
20%
Low Serum
20%
Social Deficits
20%
Vineland Adaptive Behavior Scales
20%
Neuromodulation
20%
Anandamide
20%
Low BMI
20%
Endogenous Substances
20%
Correction for multiple Comparison
20%
Medication Use
20%
Stratification Biomarker
20%
ADOS-2
20%
Endocannabinoid Tone
20%
Social Responsiveness Scale
20%
N-arachidonoylethanolamine
20%
Comprehensive Assessment
20%
Neuroscience
Pervasive Developmental Disorder
100%
Endocannabinoid
100%
Endocannabinoid System
40%
Body Mass Index
30%
Arachidonic Acid
20%
2-Arachidonoylglycerol
20%
Behavior (Neuroscience)
10%
Synaptic Plasticity
10%
Scanning Electron Microscopy
10%
Liquid Chromatography-Mass Spectrometry
10%
Neuromodulation
10%
Anandamide
10%
Endogenous Compound
10%